Miconazole induces aneuploidy-mediated tolerance in Candida albicans that is dependent on Hsp90 and calcineurin
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index; 2 of the 4 sources its claims cite were checked for support.
Abstract
Antifungal resistance and antifungal tolerance are two distinct terms that describe different cellular responses to drugs. Antifungal resistance describes the ability of a fungus to grow above the minimal inhibitory concentration (MIC) of a drug. Antifungal tolerance describes the ability of drug susceptible strains to grow slowly at inhibitory drug concentrations. Recent studies indicate antifungal resistance and tolerance have distinct evolutionary trajectories. Superficial candidiasis bothers millions of people yearly. Miconazole has been used for topical treatment of yeast infections for over 40 years. Yet, fungal resistance to miconazole remains relatively low. Here we found different clinical isolates of Candida albicans had different profile of tolerance to miconazole, and the tolerance was modulated by physiological factors including temperature and medium composition. Exposure of non-tolerant strains with different genetic backgrounds to miconazole mainly induced development of tolerance, not resistance, and the tolerance was mainly due to whole chromosomal or segmental amplification of chromosome R. The efflux gene CDR1 was required for maintenance of tolerance in wild type strains but not required for gain of aneuploidy-mediated tolerance. Heat shock protein Hsp90 and calcineurin were essential for maintenance as well as gain of tolerance. Our study indicates development of aneuploidy-mediated tolerance, not resistance, is the predominant mechanism of rapid adaptation to miconazole in C. albicans , and the clinical relevance of tolerance deserves further investigations.
Overview
CoChat Summary
## TL;DR
Miconazole tolerance in *Candida albicans* is strain- and environment-dependent, but exposure to miconazole usually leads to tolerance rather than resistance. The dominant mechanism of acquired tolerance was aneuploidy of chromosome R, and both Hsp90 and calcineurin were required for maintaining and developing this tolerance.
## Key findings
- In three *C. albicans* strains (SC5314, YJB-T1891, YJB-T490), miconazole tolerance differed by strain background and was modulated by temperature and medium; for example, on YPD agar SC5314 tolerated 1 μg/mL only at 37°C, while on SDC agar all strains tolerated only 0.015 μg/mL miconazole.
- After exposure of SC5314 to 0.008–2 μg/mL miconazole, 76/81 adaptors were tolerant, but none showed altered inhibition-zone radius, indicating tolerance rather than resistance; diskImageR showed FoG20 increased from 0.11 ± 0.05 in the parent to 0.53 ± 0.11 in adaptors, while RAD20 did not change significantly.
- Whole-genome sequencing of 36 tolerant SC5314 adaptors showed chromosome R trisomy in all cases (27 with full ChrR trisomy and 9 with duplication of one ChrR homolog); the two less tolerant adaptors sequenced were euploid.
- In the non-tolerant clinical isolate YJB-T490, 62/81 adaptors were tolerant and sequencing of 26 tolerant adaptors found ChrR aneuploidy in all of them, mostly segmental trisomy of ChrR (24/26), with 2/26 showing whole-chromosome trisomy.
## Methods
- The study tested wild-type/reference and clinical *C. albicans* isolates, plus knockout strains, using disk diffusion assays and spot assays on YPD and SDC media at 30°C and 37°C.
- To assess acquired tolerance, cells were plated on miconazole-containing media, 9–30 colonies were randomly selected from each condition, and adaptors were re-tested for tolerance; selected adaptors were sequenced by DNA-seq and analyzed with YMAP.
- Gene deletion strains were constructed with a NAT1 flipper cassette; Hsp90 function was perturbed with the inhibitor NVP-HSP990, and calcineurin pathway genes CMP1, CNB1, and CRZ1 were deleted to test dependence of tolerance.
## Limitations
- The paper states that the clinical relevance of miconazole tolerance “deserves further investigations” and that further studies are required to assess its prevalence in clinical isolates before and after azole treatment.
- It is not stated whether the observed ChrR aneuploidy is causal beyond association, although the experiments strongly link it to tolerance.
- The text makes evident that some analyses are limited to in vitro agar-based assays and a small set of strains; this may limit generalizability to broader clinical settings.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures










Verification
Claims the paper makes
2 Valid · 1 Not valid · 1 Not checked · 33 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“It seems the medium effect is drug-specific, since previous studies indicate SC5314 is tolerant to ketoconazole but not tolerant to fluconazole on SDC-agar plates at both 30°C and 37°C”
§ Miconazole induces aneuploidy-mediated tolerance in Candida albicans that is dependent on Hsp90 and calcineurin > Discussion
What the sources say
- Not matchedcites Xu et al., 2021
This doesn’t read as a citation we can look up.
- Partly supportedcites Yang et al., 2023 matched to “Antifungal Tolerance and Resistance Emerge at Distinct Drug Concentrations and Rely upon Different Aneuploid Chromosomes” (2023) sourceExperimental — accuracy not yet measured
The Results section (page unavailable) reports that medium composition affects fluconazole tolerance and that SC5314 is not fluconazole-tolerant on SDC plates at either 30°C or 37°C. It also says earlier work found medium effects on ketoconazole tolerance, but does not establish ketoconazole tolerance on SDC plates at those temperatures. The paper does not address miconazole tolerance, as stated in the supplied claim. (LLM, conf=0.84)
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, cells with suppressed Hsp90 could not develop resistance or tolerance to MCZ.”
§ Miconazole induces aneuploidy-mediated tolerance in Candida albicans that is dependent on Hsp90 and calcineurin > Results > Hsp90 is required for miconazole tolerance and resistance
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the tolerance was mainly due to whole chromosomal or segmental amplification of chromosome R.”
- Also stated in: § Tolerance is due to formation of chromosome R trisomy · plain
“All the 36 sequenced adaptors had chromosome R trisomy (ChrRx3): 27, and 9 adaptors had duplication of A and B holomog, respectively”
- Also stated in: § Exposure of non-tolerant clinical isolate to miconazole induces gain of tolerance mediated by segmental or whole chromosomal amplification of chromosome R · plain
“All the 26 adaptors were aneuploid of ChrR.”
§ Miconazole induces aneuploidy-mediated tolerance in Candida albicans that is dependent on Hsp90 and calcineurin > Abstract Antifungal resistance and antifungal tolerance are two distinct terms that describe different cellular responses to drugs. Antifungal resistance describes the ability of a fungus to grow above the minimal inhibitory concentration (MIC) of a drug. Antifungal tolerance describes the ability of drug susceptible strains to grow slowly at inhibitory drug concentrations. Recent studies indicate antifungal resistance and tolerance have distinct evolutionary trajectories. Superficial candidiasis bothers millions of people yearly. Miconazole has been used for topical treatment of yeast infections for over 40 years. Yet, fungal resistance to miconazole remains relatively low. Here we found different clinical isolates of Candida albicans had different profile of tolerance to miconazole, and the tolerance was modulated by physiological factors including temperature and medium composition. Exposure of non-tolerant strains with different genetic backgrounds to miconazole mainly induced development of tolerance, not resistance, and the tolerance was mainly due to whole chromosomal or segmental amplification of chromosome R. The efflux gene CDR1 was required for maintenance of tolerance in wild type strains but not required for gain of aneuploidy-mediated tolerance. Heat shock protein Hsp90 and calcineurin were essential for maintenance as well as gain of tolerance. Our study indicates development of aneuploidy-mediated tolerance, not resistance, is the predominant mechanism of rapid adaptation to miconazole in C. albicans, and the clinical relevance of tolerance deserves further investigations.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Tolerance is due to formation of chromosome R trisomy · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Heat shock protein Hsp90 and calcineurin were essential for maintenance as well as gain of tolerance.”
- Also stated in: § Hsp90 is required for miconazole tolerance and resistance · plain
“Thus, inhibition of Hsp990 caused decreased tolerance and resistance to MCZ.”
- Also stated in: § Hsp90 is required for miconazole tolerance and resistance · plain
“Thus, cells with suppressed Hsp90 could not develop resistance or tolerance to MCZ.”
§ Miconazole induces aneuploidy-mediated tolerance in Candida albicans that is dependent on Hsp90 and calcineurin > Abstract Antifungal resistance and antifungal tolerance are two distinct terms that describe different cellular responses to drugs. Antifungal resistance describes the ability of a fungus to grow above the minimal inhibitory concentration (MIC) of a drug. Antifungal tolerance describes the ability of drug susceptible strains to grow slowly at inhibitory drug concentrations. Recent studies indicate antifungal resistance and tolerance have distinct evolutionary trajectories. Superficial candidiasis bothers millions of people yearly. Miconazole has been used for topical treatment of yeast infections for over 40 years. Yet, fungal resistance to miconazole remains relatively low. Here we found different clinical isolates of Candida albicans had different profile of tolerance to miconazole, and the tolerance was modulated by physiological factors including temperature and medium composition. Exposure of non-tolerant strains with different genetic backgrounds to miconazole mainly induced development of tolerance, not resistance, and the tolerance was mainly due to whole chromosomal or segmental amplification of chromosome R. The efflux gene CDR1 was required for maintenance of tolerance in wild type strains but not required for gain of aneuploidy-mediated tolerance. Heat shock protein Hsp90 and calcineurin were essential for maintenance as well as gain of tolerance. Our study indicates development of aneuploidy-mediated tolerance, not resistance, is the predominant mechanism of rapid adaptation to miconazole in C. albicans, and the clinical relevance of tolerance deserves further investigations.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Hsp90 is required for miconazole tolerance and resistance · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“All the other 76 adaptors were tolerant.”
§ Miconazole induces aneuploidy-mediated tolerance in Candida albicans that is dependent on Hsp90 and calcineurin > Results > Exposure of SC5314 to miconazole induces gain of tolerance, not resistance, to miconazole
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
20 more claims
Create a free account to see all 37 claims and every source verdict.
- Probably not a substantial claim. 5
- Borderline: one of the tests for a substantial claim is unclear. 1
- It may state two separate claims as one. 8
Citations
Cites
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174
Tackling the emerging threat of antifungal resistance to human health
Fisher, M. C., Alastruey-Izquierdo, A., Berman, J., Bicanic, T., Bignell, E. M., Bowyer, P., Bromley, M., Brüggemann, R., Garber, G., Cornely, O. A., et al. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00720-1 · Cited by 1,179
Candida albicans Biofilms and Human Disease
Nobile, C. J., & Johnson, A. D. (2015) · Annual Review of Microbiology · doi:10.1146/annurev-micro-091014-104330 · Cited by 1,057
Aneuploidy and Isochromosome Formation in Drug-Resistant Candida albicans
Selmecki, A., Forche, A., & Berman, J. (2006) · Science · doi:10.1126/science.1128242 · Cited by 733 · cited 1×
“Resistance to azoles in clinical isolates is mainly due to ampli fi cation of the left arm of chromosome 5, while tolerance to azoles in vitro is mainly due to trisomy of chromosome R (Selmecki et al., 2006; Kukurudz et al., 2022; Todd et al., 2023; Yang et al., 2023).”
BackgroundDrug resistance and tolerance in fungi.
Berman, J., & Krysan, D. J. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0322-2 · Cited by 642
Endogenous Reactive Oxygen Species Is an Important Mediator of Miconazole Antifungal Effect
Kobayashi, D., Kondo, K., Uehara, N., Otokozawa, S., Tsuji, N., Yagihashi, A., & Watanabe, N. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.10.3113-3117.2002 · Cited by 338
Aneuploidy causes proteotoxic stress in yeast
Oromendia, A. B., Dodgson, S. E., & Amon, A. (2012) · Genes & Development · doi:10.1101/gad.207407.112 · Cited by 313 · cited 1×
“In yeasts, aneuploidy often leads to proportional transcriptional and translational change of genes on aneuploid chromosomes, thereby eliciting proteotoxic stress and impairing cellular protein folding (Oromendia et al., 2012).”
BackgroundEne, I. V., Adya, A. K., Wehmeier, S., Brand, A. C., MacCallum, D. M., Gow, N. A. R., & Brown, A. J. P. (2012) · Cellular Microbiology · doi:10.1111/j.1462-5822.2012.01813.x · Cited by 313 · cited 1×
“Growth medium also regulates drug resistance and bio fi lm formation in both bacteria and yeasts (Huys et al., 2002; Nayak et al., 2002; Ene et al., 2012; Serrano-Fujarte et al., 2015; Wijesinghe et al., 2019).”
BackgroundEconazole: A Review of its Antifungal Activity and Therapeutic Efficacy
Heel, R. C., Brogden, R. N., Speight, T. M., & Avery, G. S. (1978) · Drugs · doi:10.2165/00003495-197816030-00001 · Cited by 296
Rosenberg, A., Ene, I. V., Bibi, M., Zakin, S., Segal, E. S., Ziv, N., Dahan, A. M., Colombo, A. L., Bennett, R. J., & Berman, J. (2018) · Nature Communications · doi:10.1038/s41467-018-04926-x · Cited by 270
Essential role of calcineurin in response to endoplasmic reticulum stress
Bonilla, M., Nastase, K. K., & Cunningham, K. W. (2002) · The EMBO Journal · doi:10.1093/emboj/21.10.2343 · Cited by 255 · cited 1×
“Accumulation of unfolded proteins and inhibition of ergosterol synthesis in the endoplasmic reticulum stimulate an in fl ux of Ca 2+ , which promotes cell survival by activating calcineurin (Bonilla et al., 2002).”
BackgroundA recyclableCandida albicans URA3 cassette for PCR product-directed gene disruptions
Wilson, R. B., Davis, D. A., Enloe, B. M., & Mitchell, A. P. (2000) · Yeast · doi:10.1002/(sici)1097-0061(20000115)16:1<65::aid-yea508>3.0.co;2-m · Cited by 250
Juvvadi, P. R., Lee, S. C., Heitman, J., & Steinbach, W. J. (2017) · Virulence · doi:10.1080/21505594.2016.1201250 · Cited by 172
Emerging Antifungal Targets and Strategies
Ivanov, M., Ćirić, A., & Stojković, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052756 · Cited by 160 · cited 1×
“Miconazole (MCZ) is a synthetic imidazole derivative that has potent antifungal ef fi cacy when being used topically against a wide variety of yeasts and dermatophytes (Sawyer et al., 1975; Ivanov et al., 2022).”
BackgroundGenetic Architecture of Hsp90-Dependent Drug Resistance
Cowen, L. E., Carpenter, A. E., Matangkasombut, O., Fink, G. R., & Lindquist, S. (2006) · Eukaryotic Cell · doi:10.1128/ec.00274-06 · Cited by 159
Shen, J., Guo, W., & Köhler, J. R. (2005) · Infection and Immunity · doi:10.1128/iai.73.2.1239-1242.2005 · Cited by 155
Abbey, D. A., Funt, J., Lurie-Weinberger, M. N., Thompson, D. A., Regev, A., Myers, C. L., & Berman, J. (2014) · Genome Medicine · doi:10.1186/s13073-014-0100-8 · Cited by 147
Miconazole: A Review of its Antifungal Activity and Therapeutic Efficacy
Sawyer, P. R., Brogden, R. N., Pinder, R. M., Speight, T. M., & Avery, G. S. (1975) · Drugs · doi:10.2165/00003495-197509060-00002 · Cited by 143
Onyewu, C., Wormley, F. L., Perfect, J. R., & Heitman, J. (2004) · Infection and Immunity · doi:10.1128/iai.72.12.7330-7333.2004 · Cited by 121
Wijesinghe, G., Dilhari, A., Gayani, B., Kottegoda, N., Samaranayake, L., & Weerasekera, M. (2019) · Medical Principles and Practice · doi:10.1159/000494757 · Cited by 117
Huys, G., D'Haene, K., & Swings, J. (2002) · Letters in Applied Microbiology · doi:10.1046/j.1472-765x.2002.01109.x · Cited by 110
Menezes, D. L., Taverna, P., Jensen, M. R., Abrams, T., Stuart, D., Yu, G. K., Duhl, D., Machajewski, T., Sellers, W. R., Pryer, N. K., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0667 · Cited by 87
Serrano‐Fujarte, I., López-Romero, E., Reyna-López, G. E., Martínez-Gámez, M. A., Vega‐González, A., & Cuéllar‐Cruz, M. (2015) · BioMed Research International · doi:10.1155/2015/783639 · Cited by 74
The fitness costs and benefits of trisomy of each Candida albicans chromosome
Yang, F., Todd, R. T., Selmecki, A., Jiang, Y.-Y., Cao, Y.-B., & Berman, J. (2021) · Genetics · doi:10.1093/genetics/iyab056 · Cited by 72
Miconazole Induces Changes in Actin Cytoskeleton prior to Reactive Oxygen Species Induction in Yeast
Thevissen, K., Ayscough, K. R., Aerts, A. M., Du, W., De Brucker, K., Meert, E. M. K., Ausma, J., Borgers, M., Cammue, B. P. A., & François, I. E. J. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608505200 · Cited by 68
Gerstein, A. C., Rosenberg, A., Hecht, I., & Berman, J. (2016) · Microbiology · doi:10.1099/mic.0.000295 · Cited by 63 · cited 2×
“Usually, 20% drug inhibition (RAD 20 and FoG 20 ) is used to measure resistance and tolerance, respectively (Gerstein et al., 2016; Rosenberg et al., 2018).”
MethodChen, L., Zhang, L., Xie, Y., Wang, Y., Tian, X., Fang, W., Xue, X., & Wang, L. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115007 · Cited by 63
Yang, F., Scopel, E. F. C., Li, H., Sun, L.-L., Kawar, N., Cao, Y.-B., Jiang, Y.-Y., & Berman, J. (2023) · mBio · doi:10.1128/mbio.00227-23 · Cited by 62
Antifungal Drug Concentration Impacts the Spectrum of Adaptive Mutations in Candida albicans
Todd, R. T., Soisangwan, N., Peters, S., Kemp, B., Crooks, T., Gerstein, A., & Selmecki, A. (2023) · Molecular Biology and Evolution · doi:10.1093/molbev/msad009 · Cited by 53 · cited 3×
“In C. albicans , tolerance to fl uconazole has been well characterized (Rosenberg et al., 2018; Todd et al., 2023; Yang et al., 2023).”
BackgroundMiconazole Revisited: New Evidence of Antifungal Efficacy from Laboratory and Clinical Trials
Barasch, A., & Griffin, A. V. (2008) · Future Microbiology · doi:10.2217/17460913.3.3.265 · Cited by 52 · cited 1×
“Despite the wide availability and use of MCZ, fungal resistance to this drug remains relatively low (Barasch and Grif fi n, 2008).”
BackgroundTreatment of superficial mycoses: review. Part II
Dias, M. F. R. G., Bernardes-Filho, F., Quaresma-Santos, M. V. P., Amorim, A. G. D. F., Schechtman, R. C., & Azulay, D. R. (2013) · Anais Brasileiros de Dermatologia · doi:10.1590/abd1806-4841.20132018 · Cited by 42
Beyond resistance: antifungal heteroresistance and antifungal tolerance in fungal pathogens
Yang, F., & Berman, J. (2024) · Current Opinion in Microbiology · doi:10.1016/j.mib.2024.102439 · Cited by 42 · cited 1×
“While the antifungal potency of azoles may be compromised by the development of resistance and tolerance, it can be potentiated by certain adjuvants, including inhibitors of Hsp90, calcineurin, sphingolipid biosynthesis, and protein kinase C [reviewed in (Yang and Berman, 2024)].”
BackgroundMultifactorial Mechanisms of Tolerance to Ketoconazole in Candida albicans
Xu, Y., Lu, H., Zhu, S., Li, W.-Q., Jiang, Y.-Y., Berman, J., & Yang, F. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00321-21 · Cited by 35
Self-citationKukurudz, R. J., Chapel, M., Wonitowy, Q., Adamu Bukari, A.-R., Sidney, B., Sierhuis, R., & Gerstein, A. C. (2022) · G3 · doi:10.1093/g3journal/jkac156 · Cited by 35
Regidor, P. A., Thamkhantho, M., Chayachinda, C., & Palacios, S. (2023) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2023.2195001 · Cited by 31 · cited 2×
“MCZ has been widely and successfully used for many candidal infections for more than 40 years (Regidor et al., 2023).”
BackgroundSmall molecules restore azole activity against drug-tolerant and drug-resistant Candida isolates
Alabi, P., Gautier, C., Murphy, T. P., Gu, X., Lepas, M., Aimanianda, V., Sello, J. K., & Ene, I. V. (2023) · mBio · doi:10.1128/mbio.00479-23 · Cited by 30 · cited 1×
“A recent study by Ene et al. revealed that a small molecule called 1,4-benzodiazepines sensitized both resistant and tolerant strains of C. albicans to fl uconazole (Alabi et al., 2023).”
BackgroundTrachtulcov�, P., Janatov�, I., Kohlwein, S. D., & ek, J. H. (2000) · Yeast · doi:10.1002/(sici)1097-0061(20000115)16:1 · Cited by 27
Aneuploidy Mediates Rapid Adaptation to a Subinhibitory Amount of Fluconazole in Candida albicans
Sun, L.-L., Li, H., Yan, T.-H., Fang, T., Wu, H., Cao, Y.-B., Lu, H., Jiang, Y.-Y., & Yang, F. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.03016-22 · Cited by 17
Nayak, R., Khan, S. A., Watson, R. H., & Cerniglia, C. E. (2002) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2002.tb11340.x · Cited by 16
Research works printed but not linked: 1
- Institute, C.a.L.S. (2009). Method for antifungal disk diffusion susceptibility testing of yeasts. 2nd ed. (Wayne, PA: C.a.L.S. Institute).
Cited by
Zheng, L., Xu, Y., Wang, C., & Guo, L. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1450557 · Cited by 14
Self-citationParallel evolution of fluconazole resistance and tolerance in Candida glabrata
Zheng, L., Xu, Y., Wang, C., Dong, Y., & Guo, L. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1456907 · Cited by 16
“Exposure to high concentrations of other azoles, such as posaconazole and miconazole, also induces tolerance, not resistance, in C. albicans (Kukurudz et al., 2022; Guo et al., 2024).”
BackgroundMethodInfluentialSelf-citationWei, Y., Wang, J., Tang, N., Lin, Z., Li, W., Xu, Y., & Guo, L. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1618815 · Cited by 7
Self-citationZheng, L., Dong, Y., Wang, J., Jia, Y., Wang, W., Xu, Y., & Guo, L. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1519323 · Cited by 7
Self-citationZheng, L., Dong, Y., Wang, J., Zhang, M., Xu, Y., Ma, L., & Guo, L. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1528341 · Cited by 2
“Disk diffusion assays were performed according to the protocols outlined in our previous studies (Guo et al., 2024; Zheng et al., 2024b; Zheng et al., 2024c), following the CLSI M44-A2 guidelines for antifungal disk diffusion susceptibility testing (CLSI, 2009), with minor modifications.”
Self-citation
Metadata
- Authors
- Guo, L., Zheng, L., Dong, Y., Wang, C., Deng, H., Wang, Z., & Xu, Y.
- Affiliations
- Second Affiliated Hospital of Soochow University (CN)
- Corresponding author
- Xu, Yi
- Venue
- Frontiers in Cellular and Infection Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2024-06-25
- Volume
- 14
- Pages
- 1392564-1392564
- ISSN
- 2235-2988 (ISSN-L)
- PMC
- PMC11231705
- OpenAlex
- W4400010459
- Semantic Scholar
- 425a40687f10eef894df60979dda7fffe2221c37
- Cited by
- 10
- References
- 39
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 2
- FWCI
- 3.44
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Cellular and Infection Microbiology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Keywords
- miconazole, Candida albicans, antifungal tolerance, aneuploidy, HSP90, calcineurin, superficial candidiasis, antifungal resistance, clinical isolates, temperature effects, medium composition
- MeSH terms
- Aneuploidy, Antifungal Agents, Candida albicans, Candidiasis, Drug Tolerance, Fungal Proteins, Humans, Miconazole, Microbial Sensitivity Tests, HSP90 Heat-Shock Proteins, Calcineurin, Drug Resistance, Fungal, Membrane Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.